Efficacy and Safety of Celivarone, With Amiodarone as Calibrator, in Patients With an Implantable Cardioverter-Defibrillator for Prevention of Implantable Cardioverter-Defibrillator Interventions or Death The ALPHEE Study

Kowey, Peter; Crijns, Harry; Aliot, KIVANÇ; Capucci, Alessandro; Kulakowski, Piotr; Radzik, David; Roy, Denis; Connolly, Stuart; Hohnloser, Stefan

doi:10.1161/circulationaha.111.072561

Efficacy and Safety of Celivarone, With Amiodarone as Calibrator, in Patients With an Implantable Cardioverter-Defibrillator for Prevention of Implantable Cardioverter-Defibrillator Interventions or Death The ALPHEE Study

Kowey P. R., Crijns H. J. G. M., Aliot E. M., Capucci A., Kulakowski P., Radzik D., ...Daha Fazla

CIRCULATION, cilt.124, sa.24, ss.2649-2667, 2011 (SCI-Expanded, Scopus)

Yayın Türü: Makale / Tam Makale
Cilt numarası: 124 Sayı: 24
Basım Tarihi: 2011
Doi Numarası: 10.1161/circulationaha.111.072561
Dergi Adı: CIRCULATION
Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus
Sayfa Sayıları: ss.2649-2667
Anahtar Kelimeler: celivarone, implanted cardioverter defibrillators, sudden death, ventricular arrhythmia, ANTIARRHYTHMIC-DRUGS, ATRIAL-FIBRILLATION, IN-VIVO, SSR149744C, SOTALOL, SHOCKS, TRIAL
İstanbul Üniversitesi-Cerrahpaşa Adresli: Hayır

Özet

Background-Celivarone is a new antiarrhythmic agent developed for the treatment of ventricular arrhythmias. This study investigated the efficacy and safety of celivarone in preventing implantable cardioverter-defibrillator (ICD) interventions or death.